OTCMKTS:BPSR Organicell Regenerative Medicine (BPSR) Stock Price, News & Analysis $2.09 +0.09 (+4.50%) (As of 12/20/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisChartFinancialsSEC Filings About Organicell Regenerative Medicine Stock (OTCMKTS:BPSR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BPSR alerts:Sign Up Key Stats Today's Range$2.00▼$2.1850-Day Range$0.06▼$4.0052-Week Range$0.04▼$0.63Volume3,557 shsAverage Volume3.31 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewBiotech Products Services & Research, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. The firm also focuses on processing, distribution and supply of biologically processed cellular and tissue-based products developed from internally based research and development activities and also provides healthcare, anti-aging, and regenerative services. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Miami, FL.Read More… Receive BPSR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organicell Regenerative Medicine and its competitors with MarketBeat's FREE daily newsletter. Email Address BPSR Stock News HeadlinesOrganicell Regenerative Medicine Inc (OTC:OCEL) Stock Quotes, Forecast and News SummaryOctober 17, 2024 | benzinga.comZeo ScientifiX, Inc. (ZEOX)July 20, 2024 | finance.yahoo.comURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.December 22, 2024 | Crypto Swap Profits (Ad)ZEO ScientifiX, Inc.: Organicell Regenerative Medicine Rebranding to ZEO ScientifiXMarch 4, 2024 | finanznachrichten.deOrganicell Regenerative Medicine Inc (OCELD)December 17, 2023 | uk.investing.comOCELD Organicell Regenerative Medicine, Inc.December 2, 2023 | seekingalpha.comOrganicell Regenerative Stock (OTC:OCEL) Dividends: History, Yield and DatesNovember 30, 2023 | benzinga.comOrganicell Announces 1-for-200 Reverse Stock SplitNovember 27, 2023 | finance.yahoo.comSee More Headlines BPSR Stock Analysis - Frequently Asked Questions How have BPSR shares performed this year? Organicell Regenerative Medicine's stock was trading at $1.02 at the beginning of 2024. Since then, BPSR shares have increased by 104.9% and is now trading at $2.09. View the best growth stocks for 2024 here. How do I buy shares of Organicell Regenerative Medicine? Shares of BPSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Organicell Regenerative Medicine own? Based on aggregate information from My MarketBeat watchlists, some other companies that Organicell Regenerative Medicine investors own include Aurora Cannabis (ACB), NVIDIA (NVDA), 22nd Century Group (XXII), BioNTech (BNTX), Evofem Biosciences (EVFM), Inseego (INSG) and American Lithium (LIACF). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:BPSR CUSIPN/A CIK1557376 Webwww.bespoketricycles.com Phone(888) 963-7881FaxN/AEmployees18Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report This page (OTCMKTS:BPSR) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organicell Regenerative Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organicell Regenerative Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.